Genitourinary tract patent update

Bibliography

• World Health Organization 1st International Consultation on Incontinence. Abrams P, Khoury S, Wein A (Eds.), Plymbridge Distributors, Plymouth, UK (1999).
   Google Scholar
• DE GROAT WC: Neurobiology of Incontinence. Ciba Foundation Symposium (1990) 151:27.
   PubMedGoogle Scholar
• ANDERSSON K-E: Current concepts in the treatment of disorders of micturition. Drugs (1988) 35:477–494.
   PubMed Web of Science ®Google Scholar
• EGLEN RM, WATSON N: Selective muscarinic receptor agonists and antagonists. Pharmacol. Toxicol. (1996) 78:59–68.
   PubMedGoogle Scholar
• HEGDE SS, EGLEN RM: Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder. Life Sci. (1999) 64:419–428.
   PubMed Web of Science ®Google Scholar
• SOMOGYI GT, DE GROAT WC: Function, signal transduction mechanisms and plasticity of presynaptic muscarinic receptors in the urinary bladder. Life Sci. (1999) 64(6/7):411–418.
   Google Scholar
• ABRAMS P, FREEMAN R, ANDERSTROM C et al.:, a new antimuscarinic agent: as effective but better tolerated than oxybutynin in patients with an overactive bladder. Br. J. Urol. (1998) 81:801–810.
   PubMedGoogle Scholar
• APPELL RA, ANDERSON RU, GITTELMAN M et al.:Comparison of urge incontinence treatments. Neurol. Urodynam. (1999) 18:376–377.
   Google Scholar
• WEESE DI, ROSKAMP DA, LEACH GE et al.: Intravesical oxybutynin hydrochloride: experience with 42 patients. Urology (1993) 41(6):527–530.
   PubMedGoogle Scholar
• SUNDIN T, DAHLSTROM A: The sympathetic innerva-tion of the urinary bladder and urethra in the normal state and after parasympathetic denervation at the spinal root level. Scand.J. Urol. Nephrol. (1973) 7:131–149.
   PubMed Web of Science ®Google Scholar
• SEIFERTH J: Type of neurogenic bladder in children with spina bifida and response to treatment with phenoxybenzamine. Dev. Med. Child Neurol. Suppl. (1976) 18:94–96.
   Google Scholar
• PERLBERG S AND CAINE M: Adrenergic response of bladder muscle in prostatic obstruction. Urology (1982) 20:524–537.
   PubMedGoogle Scholar
• SWIERZEWSKI SJ, GORMLEY EA, BELVILLE WD et al.: Theeffect of terazosin on bladder function in the spinal cord injured. j Urol. (1994) 151:2951–2954.
   Google Scholar
• DIOKNO A, TAUB M: Ephedrine in treatment of urinaryincontinence. Urology (1975) 5(5):624–625.
   PubMedGoogle Scholar
• AWAD SA, DOWNIE JW, KIRULATA HG: Alpha adrenergic agents in urinary disorders of the proximal urethra. Part 1: sphincteric incontinence. Br. J Urol. (1978) 50:332–335.
   Google Scholar
• COLLSTE L, LINDSKOG M: Phenypropanolamine intreatment of female stress urinary incontinence. Double-blind placebo-controlled study in 24 patients. Urology (1987) 30 (4):398–403.
   Google Scholar
• AMARK P, NERGARDH A, KINN AC: The effect of noradrenaline on the contractile response of the urinary bladder. Scand. J. Urol. Nephrol. (1986) 20:203–207.
   PubMed Web of Science ®Google Scholar
• LEVIN RM, RUGGIERI MR, WEIN AJ: Identification ofreceptor subtypes in the rabbit and human urinary bladder by selective radioligand binding. j Urol (1988) 139:844–848.
   PubMed Web of Science ®Google Scholar
• NERGARDH A, BOREUS LO, NAGLO AS: Characterizationof the adrenergic beta-receptors in the urinary bladder of man and cat. Acta Pharacol Toxicol. (1977) 40:14–21.
   PubMedGoogle Scholar
• LARSEN JJ: Alpha and Beta-adrenoceptors in thedetrusor muscle and bladder base of the pig and 13-adrenoceptors in the detrusor of man. Br. J Urol (1979) 65:215–222.
   Google Scholar
• IGAWA Y, NISHIZAWA O, YAMAZAKI Y et al.: Functional and molecular biological evidence of 133-adrenocep tors in the human detrusor. j Urol (1997) 157:175. (Abstract 677)
   Google Scholar
• CASTLEDEN CM, MORGAN B: The effect of I3-adrenoce-ptor agonists on urinary incontinence in the elderly.. J. Clin. Pharmacol. (1980) 10:619–620.
   Google Scholar
• GRUNEBERGER A: Treatment of motor urge inconti-nence with clenbuterol and flaxolate hydrochloride.. J. Obstet. Gynecol (1984) 91:275–278.
   Google Scholar
• ANDERSSON K-E: Clinical pharmacology of potassium channel openers. Pharmacol. Toxicol. (1992) 70:244–254.
   PubMedGoogle Scholar
• ANDERSSON K-E: The overactive bladder: pharma-cologic basis of drug treatment. Urology(1997) 50 (Suppl. 6A):74–84.
   Google Scholar
• BRADING A: The Autonomic Nervous System and its Effectors. Blackwell Science Ltd., Oxford (1999):198.
   Google Scholar
• ANDERSSON K-E: Pharmacology of lower urinary tractsmooth muscles and penile erectile tissues. Pharmacol. Rev. (1993) 45:253–308.
   PubMedGoogle Scholar
• MAGGI CA: The dual, sensory and 'efferent' function ofthe capsaicin-sensitive primary sensory neurons in the urinary bladder and urethra. In: The Autonomic Nervous System (Volume 6). London, Harwood Academic Publishers (1993):383–422.
   Google Scholar
• MAGGI CA: Tachykinins and calcitonin gene-relatedpeptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog. Neurobiol (1995) 45:1–98.
   PubMed Web of Science ®Google Scholar
• MAGGI CA: The mammalian tachykinin receptors. Gen.. (1995) 26:911–944.
   Google Scholar
• GUILIANI S, PATACCHINI R, BARBANTI G et al: Charac-terization of the tachykinin neurokinin-2 receptors in the human urinary bladder by means of selective receptor antagonists and peptidase inhibitors. J. Pharmacol. Exp. Ther. (1993) 267:590–595.
   PubMedGoogle Scholar
• ZENG X-P, MOORE KH, BURCHER E: Characterization of tachykinin NK-2 receptors in human urinary bladder.. (1995) 153:1688–1692.
   Google Scholar
• PALEA S, CORSI M, ARTIBANI W et al.: Pharmacological characterization of tachykinin NK-2 receptors on isolated human urinary bladder, prostatic urethra and prostate. J. Pharmacol. Exp. Ther. (1996) 277:700–705.
   PubMedGoogle Scholar
• ANDERSSON KE, PERSSON K: The L-arginine/nitric oxide pathway and non-adrenergic, non-cholinergic relaxation of the lower urinary tract. Gen. Pharmacol (1993) 24: 833–839.
   PubMedGoogle Scholar
• PERSSON K, ALM P, JOHANSSON K et al: Nitric oxide synthase in pig lower urinary tract: immunohisto-chemistry, NADPH diaphorase histochemistry and functional effects. Br. J. Pharmacol. (1993) 110:521–530.
   PubMed Web of Science ®Google Scholar
• ANDERSSON KE, GARCIA-PASCUAL A, PERSSON K et al: induced nerve mediated relaxation of rabbit urethra involves nitric oxide. j Urol. (1992) 147:253–259.
   PubMed Web of Science ®Google Scholar
• BENNETT BC, KRUSE MN, ROPPOLO JR et al: Neural control of urethral outlet activity in vivo: role of nitric oxide. J Urol. (1995) 153:2004–2009.
   PubMed Web of Science ®Google Scholar
• NISHIZAWA S, IGAWA Y, OKADA N et al: Capsaicin-induced nitric-oxide dependent relaxation in isolated dog urethra. Eur.J. Pharmacol (1997) 335:211–219.
   PubMedGoogle Scholar
• CHVVALISZ, CHWALICZ K, GARFIELD RE et al: Role of progesterone during pregnancy: models of parturi-tion and preeclampsia. Z. Geburtshilfe Perinatol. (1994) 198 (5-5):170–180.
   PubMedGoogle Scholar
• GARFIELD RE, CHVVALISZ, CHWALICZ K etal.: Reversal of preeclampsia symptoms induced in rats by nitric oxide inhibition with L-arginine, steroid hormones and an endothelin antagonist. Soc. Gynecol. Invest. (1994):Abstract P384.
   Google Scholar
• MACMAHON SB, SPILLANE K: Brain stem influences on the parasympathetic supply to the urinary bladder of the cat. Brain Res. (1982) 234:237–249.
   PubMedGoogle Scholar
• STEERS WD, ALBO M, VAN ASSELT E: Effects of seroto-nergic agonists on micturition and sexual function in the rat. J. Drug Dev. Res. (1992) 27:361–375.
   Google Scholar
• MAGGI CA, BORSINI F, LECCI A et al.: The effect of acute and chronic administration of imipramine on spinal and supr aspin al micturition reflexes in rats. J. Pharmacol. Exp. Ther. (1989) 248:278–285.
   PubMedGoogle Scholar
• MALLORY BS, ROPPOLO JR, DE GROAT WC: Pharma-cological modulation of the pontine micturition center. Brain Res. (1991) 546:310–320.
   PubMed Web of Science ®Google Scholar
• ZOUBEK J, SOMOGYI GT, DE GROAT WC: A comparisonof inhibitory effects of neuropeptide Y on rat urinary, urethra and vas deferens. Am. J. Physiol. (1993) 265 :R537–R543.
   Google Scholar
• MAGGI CA: Prostanoids as local modulators of reflexmicturition. Pharmacol. Res. (1992) 25:13–20.
   PubMed Web of Science ®Google Scholar
• ISHIZUKA O, MATTIASSON A, ANDERSSON KE: Prosta-glandin E2-induced bladder hyperactivity in normal, conscious rats: involvement of tachykinins? j Urol. (1995) 153:2034-2038.
   Google Scholar
• PERSSON K, GARCIA-PASCUAL A, HOLMQUIST F et al:-1-induced contractions of isolated pig detrusor and vesical arterial smooth muscle: calcium dependence and phosphoinositide hydrolysis. Gen. Pharmacol. (1992) 23:445–453.
   PubMedGoogle Scholar
• SAENZ DE TEJADA I, MUELLER JD, DE LAS MORENAS A et in the urinary bladder. I. Synthesis of endothelin-1 by epithelia, muscle and fibroblasts suggests autocrine and paracrine cellular regenera-tion. j Urol. (1992) 148:1290–1298.
   Google Scholar
• ATALA A, KIM W, PAIGE KT et al.: Endoscopic treatment of vesicoureteral reflux with chondrocyte-alginate suspension. J Urol. (1994) 152:641.
   PubMed Web of Science ®Google Scholar
• ATALA A: Construction of artificial organs and tissue using autologous cells. AUA Update Series (2000) XIX(16):121–128.
   Google Scholar
• CILENTO BG, ATALA A: Treatment of reflux and inconti-nence with autologous chondrocytes and bladder muscle cells. Dialogues Pediatr. Urol. (1995) 18:11.
   Google Scholar
• ABRAMS P, BLAIVAS JG, STANTAN SL, ANDERSEN JT: The standardization of terminology of lower urinary tract dysfunction. Scand. J. Um]. Nephrol. Suppl. (1988) 114:5–10.
   PubMedGoogle Scholar
• APPELL RA: Clinical efficacy and safety of totter odine in the treatment of overactive bladder. Apooled analysis. (1997) 5 0:90–96.
   Google Scholar
• SOMOGYI GT, ZERNOVA GV, YOSHIYAMA M et al.: dependence of muscarinic facilitation of transmitter release in urinary bladder strips from neurally intact or chronic spinal cord transected rats. Br. J. Pharmacol. (1998) 125:241–246.
   PubMedGoogle Scholar
• BRAVERMAN AS, KOHN IJ, LUTHRIN GR et al.: Prejunc-tional M1 facilitatory and M2 inhibitory muscarinic receptors mediate rat bladder contractility. Am. J Physic)]. (1998) 274(2 Part 2): R517–R523.
   Google Scholar
• HEGDE SS, CHOPPIN A, BONHAUS D et al.: Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo. Br. J. Pharm. (1997) 1 2 0 (8):1409–1418.
   Google Scholar
• TAKEDA H, KAIDOH K, YAMAZAKI Y et al.: Effects of selective 132 and 133-adreno cep tor agonists on prostaglandin-F2 induced bladder hyperactivity and cardiovascular system in conscious rats. Neurourol Urodynam. (2000) 19(4) Abstract 68.
   Google Scholar
• HOWE BB, HALTERMAN TJ, YOCHIM CL et al.: Zeneca ZD6169: a novel Katp channel opener with in vivo selectivity for urinary bladder. J. Pharmacol. Exp. Ther. (1995) 274:884–890.
   PubMed Web of Science ®Google Scholar
• PANDITA RK, PERSSON K, ANDERSSON KE: Effects of the 10- channel opener ZD6169 on volume and PGE2-stimulated bladder activity in conscious rats. J. Urol. (1997) 158:2300–2304.
   PubMedGoogle Scholar
• YU YB, DE GROAT WC: Effect of ZD6169, a Katp channel opener, on bladder hyperactivity and spinal c-fos expression evoked by bladder irritation in rats. Res. (1998) 807:11–18.
   Google Scholar
• YU YB, DE GROAT WC: Effects of ZD6169, a K+(ATP)channel opener, on the micturition reflex in the rat. J. Pharmacol. Exp. Ther. (1999) 290:825–831.
   PubMed Web of Science ®Google Scholar
• KONTANI H, JINKAWA M, SHIRAOYA C, NAGASHIMA A:Effect of K+ channel openers, KRN2391 and Ki1769 and nitroglycerin on the urinary tract of rats in viva Jpn. Pharmacol. (1999) 80:143–153.
   Google Scholar
• DE GROAT WC, BOOTH AM, YOSHIMURA N: Neurophysiology of micturition and its modification in animal models of human disease. In: The Autonomic Nervous System Volume 3: Nervous Control of the Urogenital System. Maggi CA (Ed.) (1993):227–290.
   Google Scholar
• LECCI A, GIULIANI S, TRAMONTANA M et al.: MEN11,420,a peptide tachykinin NK-2 receptor antagonist, reduces motor responses induced by the intravesical administration of capsaicin in vivo. Naunyn-Schmiedeberg's Arch. Pharmacol. (1997) 356:182–188.
   Google Scholar
• ISHIZUKA O, IGAWA Y, LECCI A et al.: Role of intrathecaltachykinins for micturition in unanaesthetized rats with and without bladder outlet obstruction. Br. J. Pharmacol. (1994) 113:111–116.
   PubMed Web of Science ®Google Scholar
• ISHIZUKA O, MATTIASSON A, ANDERSSON KE: Effects ofneurokinin receptor antagonists on L-dopa induced bladder hyperactivity in normal conscious rats. j Uroi. (1995) 1 5 4:1548–1551.
   Google Scholar
• LECCI A, GUILIANI S, SANTICIOLI P et al.: Involvement ofspinal tachykinin NK-1 and NK-2 receptors in detrusor hyperreflexia during chemical cystitis in anaesthe-tized rats. Eur. j Pharmacol (1994) 259:129–135.
   PubMedGoogle Scholar
• CARDOZO LD, STANTON SL, ROBINSON H et al.: Evalua-tion of flurbiprofen in detrusor instability. Br. Med. J. (1980) 280:281–282.
   PubMed Web of Science ®Google Scholar
• Cardozo LD and Stanton SL: A comparison between bromocriptine and indomethacin in the treatment of detrusor instability. j Uroi. (1980) 123:399–401.
   PubMedGoogle Scholar
• YOSHIDA M, INADOME A, YONO M et al.: Effects of prostaglandin E2 receptor antagonist in overactive bladder in the chronic spinal rats. Neurol. Urodynam. (2000) 19 (4):22 (Abstract).
   Google Scholar
• BURNSTOCK G, DUMSDAY B, SMYTHE A: Atropine-resistant excitation of the urinary bladder: possibility of transmission via nerves releasing a purine nucleo-tide. Br. J. Pharmacol. (1972) 44:451.
   PubMed Web of Science ®Google Scholar
• RALEVIC V, BURNSTOCK G: Receptors for purines and pyrimidines. Pharmacol. Rev. (1998) 50:413–492.
   PubMed Web of Science ®Google Scholar
• QU Z, BALKIR L, VAN DEUTEKOM JCT, ROBBINS PD, PRUCHNIC R, HUARD J: Development of approaches to cell survival in myoblast transfer therapy. J. Cell. Biol. (1998) 142:1257–1267.
   PubMed Web of Science ®Google Scholar